INVO Fertility, Inc (NASDAQ:IVF) Sees Significant Increase in Short Interest

INVO Fertility, Inc (NASDAQ:IVF) was the target of a large growth in short interest during the month of June. As of June 30th, there was short interest totaling 760,242 shares, a growth of 461.7% from the June 15th total of 135,347 shares. Based on an average daily volume of 12,658,939 shares, the days-to-cover ratio is currently 0.1 days. Approximately 42.8% of the shares of the company are sold short.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of INVO Fertility from a “sell (e)” rating to a “sell (e+)” rating in a research report on Wednesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $20.00.

Institutional Trading of INVO Fertility

A hedge fund recently bought a new position in INVO Fertility stock. Armistice Capital LLC acquired a new stake in shares of INVO Fertility, Inc (NASDAQ:IVF) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 207,644 shares of the company’s stock, valued at approximately $156,000. Armistice Capital LLC owned about 8.69% of INVO Fertility at the end of the most recent quarter. Institutional investors own 12.02% of the company’s stock.

INVO Fertility Stock Performance

NASDAQ:IVF remained flat at $1.13 on Monday. 163,873 shares of the company’s stock traded hands, compared to its average volume of 1,806,422. The firm has a market cap of $2.02 million, a PE ratio of -0.00 and a beta of 2.28. The company has a current ratio of 0.90, a quick ratio of 0.87 and a debt-to-equity ratio of 0.05. The firm’s 50-day simple moving average is $1.58 and its two-hundred day simple moving average is $3.32. INVO Fertility has a 52-week low of $1.10 and a 52-week high of $169.60.

INVO Fertility (NASDAQ:IVF) last announced its quarterly earnings data on Monday, June 22nd. The company reported ($3.38) earnings per share (EPS) for the quarter. The firm had revenue of $2.02 million during the quarter. INVO Fertility had a negative net margin of 183.75% and a negative return on equity of 420.62%.

About INVO Fertility

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.